Clinical Trial Update: A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Entecavir Extended Release (XR) in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and pharmacokinetics of a new extended-release formulation of entecavir in healthy subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Entecavir XR (entecavir extended-release)

Snippet

Sponsor: Aucta Pharmaceuticals, Inc | Conditions: HBV | Phase 1 | Status: COMPLETED